ZRB1233
Anti-Caspase-1 (p20) Antibody, clone 2G4 , ZooMAb® Rabbit Monoclonal
recombinant, expressed in HEK 293 cells
Synonym(s):
CASP-1, EC:3.4.22.36, ICE, IL-1 beta-converting enzyme, IL-1BC, Interleukin-1 beta convertase, Interleukin-1 beta-converting enzyme, p45
Sign Into View Organizational & Contract Pricing
All Photos(14)
About This Item
UNSPSC Code:
12352203
NACRES:
NA.41
Recommended Products
biological source
rabbit (recombinant)
Quality Level
recombinant
expressed in HEK 293 cells
conjugate
unconjugated
antibody form
purified antibody
antibody product type
primary antibodies
clone
2G4, recombinant monoclonal
product line
ZooMAb® learn more
form
lyophilized
mol wt
observed mol wt ~20 kDa
observed mol wt ~45 kDa
species reactivity
human, mouse, rat
packaging
antibody small pack of 25 μL
greener alternative product characteristics
Waste Prevention
Designing Safer Chemicals
Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.
enhanced validation
recombinant expression
Learn more about Antibody Enhanced Validation
sustainability
Greener Alternative Product
technique(s)
immunocytochemistry: suitable
immunohistochemistry (formalin-fixed, paraffin-embedded sections): suitable
western blot: suitable
isotype
IgG
UniProt accession no.
greener alternative category
shipped in
ambient
storage temp.
2-8°C
target post-translational modification
unmodified
Gene Information
human ... CASP1(834)
mouse ... Casp1(12362)
rat ... Casp1(25166)
General description
We are committed to bringing you greener alternative products, which adhere to one or more of The 12 Principles of Green Chemistry.This antibody is Preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency". Click here for more information.
ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.
Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.
Learn more about ZooMAb here.
Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.
Learn more about ZooMAb here.
Specificity
Clone 2G4 is a ZooMAb rabbit recombinant monoclonal antibody that detects Caspase-1 proenzyme and the p20 subunit. It targets an epitope within 21 amino acids from the C-terminal region of p20 subunit.
Immunogen
KLH-conjugated linear peptide corresponding to 21 amino acids from the p20 subunit of human Caspase-1.
Application
Anti-Caspase-1 (p20), clone 2G4 ZooMAb, Cat. No. ZRB1233, is a recombinant Rabbit monoclonal antibody that targets Caspase-1 proenzyme and p20 subunit and has been tested for use in Immunocytochemistry, Immunohistochemistry (Paraffin), and Western Blotting.
Western Blotting Analysis: A 1:1,000 dilution from a representative lot detected Caspase-1 proenzyme and p20 subunit in rat spleen tissue lysate.
Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected Caspase-1 (p20) in NIH 3T3 cells.
Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected Caspase-1 (p20) in human small intestine tissue sections.
Note: Actual optimal working dilutions must be determined by the end user as specimens and experimental conditions may vary.
Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected Caspase-1 (p20) in NIH 3T3 cells.
Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected Caspase-1 (p20) in human small intestine tissue sections.
Note: Actual optimal working dilutions must be determined by the end user as specimens and experimental conditions may vary.
Target description
Caspase-1 (UniProt: P29466; also known as EC:3.4.22.36, CASP-1, Interleukin-1 beta convertase, IL-1BC, Interleukin-1 beta-converting enzyme, ICE, IL-1 beta-converting enzyme, p45) is encoded by the CASP1 (also known as IL1BC, IL1BCE) gene (Gene ID: 834) inn human. Caspse-1 is a thiol protease that is synthesized as a single chain zymogen, which is further processed to create active caspase-1. The zymogen has two propeptides (aa 1-119 and 298-316), that are subsequently cleaved off to generate p20 (aa 120-297) and p10 (aa 317-404) subunits. The mature enzyme consists of two anti-parallel arranged heterodimers, each formed by a p20 and a p10 subunit. The p20 subunit can also form a heterodimer with the epsilon isoform which then has an inhibitory effect. It displays a strict requirement for an aspartic acid residue at position P1 and has a preferred cleavage sequence of Tyr-Val-Ala-Asp. Caspase-1 cleaves IL-1 beta between an aspartic acid and alanine, releasing the mature cytokine which is involved in a variety of inflammatory processes. It is an important component of the inflammasome that during DNA virus infection controls antiviral immunity through cleavage of cGMP-AMP synthase (cGAS), rendering it inactive. Caspase-1 is expressed in larger amounts in spleen and lung, but is also detected in most other tissues, except for the brain. This ZooMAb recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Wang, Y., et al. (2017). Immunity. 46(3); 393-404).
Physical form
Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose, normal appearance a coarse or translucent resin. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.
Reconstitution
30 μg/mL after reconstitution at 25 μL. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
Storage and Stability
Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.
Legal Information
ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
Storage Class Code
11 - Combustible Solids
WGK
WGK 2
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Mei-Hsin Hsu et al.
Pharmaceuticals (Basel, Switzerland), 16(6) (2023-06-28)
Endothelial dysfunction is characterized by disturbances in nitric oxide (NO) bioavailability and increased circulating asymmetric dimethylarginine (ADMA) due to the enormous release of free radicals. Increased circulating ADMA may cause endothelial dysfunction and a variety of clinical disorders, such as
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service